カテゴリ： QYResearch, 世界, 医療/バイオ

デソゲストレル錠＆エチニルエストラジオール錠の世界市場2025年：短時間作用型避妊薬、長時間作用型避妊薬

■ 英語タイトル：Global Desogestrel and Ethinyl Estradiol Tablets Market Research Report 2025

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA8735）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA8735
■ 発行日：2025年3月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：95
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥417,600見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥626,400見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥835,200見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[デソゲストレル錠＆エチニルエストラジオール錠の世界市場2025年：短時間作用型避妊薬、長時間作用型避妊薬]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

本調査資料はデソゲストレル錠＆エチニルエストラジオール錠のグローバル市場について調査・分析し、世界のデソゲストレル錠＆エチニルエストラジオール錠市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（短時間作用型避妊薬、長時間作用型避妊薬）、用途別セグメント分析（病院、クリニック）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Cipla、Bayer、Merck、Teva Pharmaceutical、Allergan、Pfizer、Reckitt Benckiser、Mankind Pharma、Janssen Pharmaceutical、HLL Lifecare、Mithra Pharmaceuticalsなどが含まれています。デソゲストレル錠＆エチニルエストラジオール錠のグローバル市場は、2024年にXXX米ドル、2031年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。貿易戦争とロシア・ウクライナ戦争の影響は、デソゲストレル錠＆エチニルエストラジオール錠市場規模を算出する際に考慮しました。

・デソゲストレル錠＆エチニルエストラジオール錠市場の概要
- 製品の定義
- デソゲストレル錠＆エチニルエストラジオール錠の種類別セグメント
- 世界のデソゲストレル錠＆エチニルエストラジオール錠市場規模：タイプ別分析（短時間作用型避妊薬、長時間作用型避妊薬）
- デソゲストレル錠＆エチニルエストラジオール錠の用途別セグメント
- 世界のデソゲストレル錠＆エチニルエストラジオール錠市場規模：用途別分析（病院、クリニック）
- 世界のデソゲストレル錠＆エチニルエストラジオール錠市場規模予測（2020年-2031年）
- デソゲストレル錠＆エチニルエストラジオール錠の平均価格推移（2020年-2031年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- デソゲストレル錠＆エチニルエストラジオール錠市場の競争状況およびトレンド

・デソゲストレル錠＆エチニルエストラジオール錠の地域別市場規模
- 北米のデソゲストレル錠＆エチニルエストラジオール錠市場規模（2020年-2031年）
- 米国のデソゲストレル錠＆エチニルエストラジオール錠市場規模（2020年-2031年）
- ヨーロッパのデソゲストレル錠＆エチニルエストラジオール錠市場規模（2020年-2031年）
- アジア太平洋のデソゲストレル錠＆エチニルエストラジオール錠市場規模（2020年-2031年）
- 中国のデソゲストレル錠＆エチニルエストラジオール錠市場規模（2020年-2031年）
- 日本のデソゲストレル錠＆エチニルエストラジオール錠市場規模（2020年-2031年）
- 韓国のデソゲストレル錠＆エチニルエストラジオール錠市場規模（2020年-2031年）
- インドのデソゲストレル錠＆エチニルエストラジオール錠市場規模（2020年-2031年）
- オーストラリアのデソゲストレル錠＆エチニルエストラジオール錠市場規模（2020年-2031年）
- 中南米のデソゲストレル錠＆エチニルエストラジオール錠市場規模（2020年-2031年）
- 中東・アフリカのデソゲストレル錠＆エチニルエストラジオール錠市場規模（2020年-2031年）

・種類別セグメント：短時間作用型避妊薬、長時間作用型避妊薬
- 世界のデソゲストレル錠＆エチニルエストラジオール錠のタイプ別販売量（2020年-2025年）
- 世界のデソゲストレル錠＆エチニルエストラジオール錠のタイプ別売上（2020年-2025年）
- 世界のデソゲストレル錠＆エチニルエストラジオール錠のタイプ別価格

・用途別セグメント：病院、クリニック
- 世界のデソゲストレル錠＆エチニルエストラジオール錠の用途別販売量（2020年-2025年）
- 世界のデソゲストレル錠＆エチニルエストラジオール錠の用途別売上（2020年-2025年）
- 世界のデソゲストレル錠＆エチニルエストラジオール錠の用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
Cipla、Bayer、Merck、Teva Pharmaceutical、Allergan、Pfizer、Reckitt Benckiser、Mankind Pharma、Janssen Pharmaceutical、HLL Lifecare、Mithra Pharmaceuticals

・産業チェーンと販売チャネルの分析
- デソゲストレル錠＆エチニルエストラジオール錠産業チェーン分析
- デソゲストレル錠＆エチニルエストラジオール錠の主要原材料
- デソゲストレル錠＆エチニルエストラジオール錠の販売チャネル
- デソゲストレル錠＆エチニルエストラジオール錠のディストリビューター
- デソゲストレル錠＆エチニルエストラジオール錠の主要顧客

・デソゲストレル錠＆エチニルエストラジオール錠市場ダイナミクス
- デソゲストレル錠＆エチニルエストラジオール錠の業界動向
- デソゲストレル錠＆エチニルエストラジオール錠市場の成長ドライバ、課題、阻害要因

・調査の結論

・調査手法と情報源

Highlights
The global Desogestrel and Ethinyl Estradiol Tablets market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of % during the forecast period 2025-2031. The influence of trade war and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Desogestrel and Ethinyl Estradiol Tablets is estimated to increase from $ million in 2023 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Desogestrel and Ethinyl Estradiol Tablets is estimated to increase from $ million in 2023 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The key global manufacturers of Desogestrel and Ethinyl Estradiol Tablets include Cipla, Bayer, Merck, Teva Pharmaceutical, Allergan, Pfizer, Reckitt Benckiser, Mankind Pharma and Janssen Pharmaceutical, etc. in 2024, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Desogestrel and Ethinyl Estradiol Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Desogestrel and Ethinyl Estradiol Tablets.
The Desogestrel and Ethinyl Estradiol Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Desogestrel and Ethinyl Estradiol Tablets market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Desogestrel and Ethinyl Estradiol Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Cipla
Bayer
Merck
Teva Pharmaceutical
Allergan
Pfizer
Reckitt Benckiser
Mankind Pharma
Janssen Pharmaceutical
HLL Lifecare
Mithra Pharmaceuticals
Segment by Type
Short-acting Contraceptives
Long-acting Contraceptives
Segment by Application
Hospital
Clinic
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Desogestrel and Ethinyl Estradiol Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Desogestrel and Ethinyl Estradiol Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Desogestrel and Ethinyl Estradiol Tablets Market Overview
1.1 Product Overview and Scope of Desogestrel and Ethinyl Estradiol Tablets
1.2 Desogestrel and Ethinyl Estradiol Tablets Segment by Type
1.2.1 Global Desogestrel and Ethinyl Estradiol Tablets Market Value Comparison by Type (2025-2031)
1.2.2 Short-acting Contraceptives
1.2.3 Long-acting Contraceptives
1.3 Desogestrel and Ethinyl Estradiol Tablets Segment by Application
1.3.1 Global Desogestrel and Ethinyl Estradiol Tablets Market Value by Application: (2025-2031)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Desogestrel and Ethinyl Estradiol Tablets Market Size Estimates and Forecasts
1.4.1 Global Desogestrel and Ethinyl Estradiol Tablets Revenue 2020-2031
1.4.2 Global Desogestrel and Ethinyl Estradiol Tablets Sales 2020-2031
1.4.3 Global Desogestrel and Ethinyl Estradiol Tablets Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Desogestrel and Ethinyl Estradiol Tablets Market Competition by Manufacturers
2.1 Global Desogestrel and Ethinyl Estradiol Tablets Sales Market Share by Manufacturers (2020-2025)
2.2 Global Desogestrel and Ethinyl Estradiol Tablets Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Desogestrel and Ethinyl Estradiol Tablets Average Price by Manufacturers (2020-2025)
2.4 Global Desogestrel and Ethinyl Estradiol Tablets Industry Ranking 2023 VS 2024 VS 2025
2.5 Global Key Manufacturers of Desogestrel and Ethinyl Estradiol Tablets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Desogestrel and Ethinyl Estradiol Tablets, Product Type & Application
2.7 Desogestrel and Ethinyl Estradiol Tablets Market Competitive Situation and Trends
2.7.1 Desogestrel and Ethinyl Estradiol Tablets Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Desogestrel and Ethinyl Estradiol Tablets Players Market Share by Revenue
2.7.3 Global Desogestrel and Ethinyl Estradiol Tablets Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Desogestrel and Ethinyl Estradiol Tablets Retrospective Market Scenario by Region
3.1 Global Desogestrel and Ethinyl Estradiol Tablets Market Size by Region: 2020 Versus 2024 Versus 2025
3.2 Global Desogestrel and Ethinyl Estradiol Tablets Global Desogestrel and Ethinyl Estradiol Tablets Sales by Region: 2020-2031
3.2.1 Global Desogestrel and Ethinyl Estradiol Tablets Sales by Region: 2020-2025
3.2.2 Global Desogestrel and Ethinyl Estradiol Tablets Sales by Region: 2026-2031
3.3 Global Desogestrel and Ethinyl Estradiol Tablets Global Desogestrel and Ethinyl Estradiol Tablets Revenue by Region: 2020-2031
3.3.1 Global Desogestrel and Ethinyl Estradiol Tablets Revenue by Region: 2020-2025
3.3.2 Global Desogestrel and Ethinyl Estradiol Tablets Revenue by Region: 2026-2031
3.4 North America Desogestrel and Ethinyl Estradiol Tablets Market Facts & Figures by Country
3.4.1 North America Desogestrel and Ethinyl Estradiol Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Desogestrel and Ethinyl Estradiol Tablets Sales by Country (2020-2031)
3.4.3 North America Desogestrel and Ethinyl Estradiol Tablets Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Desogestrel and Ethinyl Estradiol Tablets Market Facts & Figures by Country
3.5.1 Europe Desogestrel and Ethinyl Estradiol Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Desogestrel and Ethinyl Estradiol Tablets Sales by Country (2020-2031)
3.5.3 Europe Desogestrel and Ethinyl Estradiol Tablets Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Desogestrel and Ethinyl Estradiol Tablets Market Facts & Figures by Country
3.6.1 Asia Pacific Desogestrel and Ethinyl Estradiol Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Desogestrel and Ethinyl Estradiol Tablets Sales by Country (2020-2031)
3.6.3 Asia Pacific Desogestrel and Ethinyl Estradiol Tablets Revenue by Country (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Desogestrel and Ethinyl Estradiol Tablets Market Facts & Figures by Country
3.7.1 Latin America Desogestrel and Ethinyl Estradiol Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Desogestrel and Ethinyl Estradiol Tablets Sales by Country (2020-2031)
3.7.3 Latin America Desogestrel and Ethinyl Estradiol Tablets Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Desogestrel and Ethinyl Estradiol Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Desogestrel and Ethinyl Estradiol Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Desogestrel and Ethinyl Estradiol Tablets Sales by Country (2020-2031)
3.8.3 Middle East and Africa Desogestrel and Ethinyl Estradiol Tablets Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Desogestrel and Ethinyl Estradiol Tablets Sales by Type (2020-2031)
4.1.1 Global Desogestrel and Ethinyl Estradiol Tablets Sales by Type (2020-2025)
4.1.2 Global Desogestrel and Ethinyl Estradiol Tablets Sales by Type (2026-2031)
4.1.3 Global Desogestrel and Ethinyl Estradiol Tablets Sales Market Share by Type (2020-2031)
4.2 Global Desogestrel and Ethinyl Estradiol Tablets Revenue by Type (2020-2031)
4.2.1 Global Desogestrel and Ethinyl Estradiol Tablets Revenue by Type (2020-2025)
4.2.2 Global Desogestrel and Ethinyl Estradiol Tablets Revenue by Type (2026-2031)
4.2.3 Global Desogestrel and Ethinyl Estradiol Tablets Revenue Market Share by Type (2020-2031)
4.3 Global Desogestrel and Ethinyl Estradiol Tablets Price by Type (2020-2031)
5 Segment by Application
5.1 Global Desogestrel and Ethinyl Estradiol Tablets Sales by Application (2020-2031)
5.1.1 Global Desogestrel and Ethinyl Estradiol Tablets Sales by Application (2020-2025)
5.1.2 Global Desogestrel and Ethinyl Estradiol Tablets Sales by Application (2026-2031)
5.1.3 Global Desogestrel and Ethinyl Estradiol Tablets Sales Market Share by Application (2020-2031)
5.2 Global Desogestrel and Ethinyl Estradiol Tablets Revenue by Application (2020-2031)
5.2.1 Global Desogestrel and Ethinyl Estradiol Tablets Revenue by Application (2020-2025)
5.2.2 Global Desogestrel and Ethinyl Estradiol Tablets Revenue by Application (2026-2031)
5.2.3 Global Desogestrel and Ethinyl Estradiol Tablets Revenue Market Share by Application (2020-2031)
5.3 Global Desogestrel and Ethinyl Estradiol Tablets Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Cipla
6.1.1 Cipla Corporation Information
6.1.2 Cipla Description and Business Overview
6.1.3 Cipla Desogestrel and Ethinyl Estradiol Tablets Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Cipla Desogestrel and Ethinyl Estradiol Tablets Product Portfolio
6.1.5 Cipla Recent Developments/Updates
6.2 Bayer
6.2.1 Bayer Corporation Information
6.2.2 Bayer Description and Business Overview
6.2.3 Bayer Desogestrel and Ethinyl Estradiol Tablets Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Bayer Desogestrel and Ethinyl Estradiol Tablets Product Portfolio
6.2.5 Bayer Recent Developments/Updates
6.3 Merck
6.3.1 Merck Corporation Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Desogestrel and Ethinyl Estradiol Tablets Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Merck Desogestrel and Ethinyl Estradiol Tablets Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Teva Pharmaceutical
6.4.1 Teva Pharmaceutical Corporation Information
6.4.2 Teva Pharmaceutical Description and Business Overview
6.4.3 Teva Pharmaceutical Desogestrel and Ethinyl Estradiol Tablets Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Teva Pharmaceutical Desogestrel and Ethinyl Estradiol Tablets Product Portfolio
6.4.5 Teva Pharmaceutical Recent Developments/Updates
6.5 Allergan
6.5.1 Allergan Corporation Information
6.5.2 Allergan Description and Business Overview
6.5.3 Allergan Desogestrel and Ethinyl Estradiol Tablets Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Allergan Desogestrel and Ethinyl Estradiol Tablets Product Portfolio
6.5.5 Allergan Recent Developments/Updates
6.6 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Desogestrel and Ethinyl Estradiol Tablets Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Pfizer Desogestrel and Ethinyl Estradiol Tablets Product Portfolio
6.6.5 Pfizer Recent Developments/Updates
6.7 Reckitt Benckiser
6.6.1 Reckitt Benckiser Corporation Information
6.6.2 Reckitt Benckiser Description and Business Overview
6.6.3 Reckitt Benckiser Desogestrel and Ethinyl Estradiol Tablets Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Reckitt Benckiser Desogestrel and Ethinyl Estradiol Tablets Product Portfolio
6.7.5 Reckitt Benckiser Recent Developments/Updates
6.8 Mankind Pharma
6.8.1 Mankind Pharma Corporation Information
6.8.2 Mankind Pharma Description and Business Overview
6.8.3 Mankind Pharma Desogestrel and Ethinyl Estradiol Tablets Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Mankind Pharma Desogestrel and Ethinyl Estradiol Tablets Product Portfolio
6.8.5 Mankind Pharma Recent Developments/Updates
6.9 Janssen Pharmaceutical
6.9.1 Janssen Pharmaceutical Corporation Information
6.9.2 Janssen Pharmaceutical Description and Business Overview
6.9.3 Janssen Pharmaceutical Desogestrel and Ethinyl Estradiol Tablets Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Janssen Pharmaceutical Desogestrel and Ethinyl Estradiol Tablets Product Portfolio
6.9.5 Janssen Pharmaceutical Recent Developments/Updates
6.10 HLL Lifecare
6.10.1 HLL Lifecare Corporation Information
6.10.2 HLL Lifecare Description and Business Overview
6.10.3 HLL Lifecare Desogestrel and Ethinyl Estradiol Tablets Sales, Revenue and Gross Margin (2020-2025)
6.10.4 HLL Lifecare Desogestrel and Ethinyl Estradiol Tablets Product Portfolio
6.10.5 HLL Lifecare Recent Developments/Updates
6.11 Mithra Pharmaceuticals
6.11.1 Mithra Pharmaceuticals Corporation Information
6.11.2 Mithra Pharmaceuticals Desogestrel and Ethinyl Estradiol Tablets Description and Business Overview
6.11.3 Mithra Pharmaceuticals Desogestrel and Ethinyl Estradiol Tablets Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Mithra Pharmaceuticals Desogestrel and Ethinyl Estradiol Tablets Product Portfolio
6.11.5 Mithra Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Desogestrel and Ethinyl Estradiol Tablets Industry Chain Analysis
7.2 Desogestrel and Ethinyl Estradiol Tablets Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Desogestrel and Ethinyl Estradiol Tablets Production Mode & Process
7.4 Desogestrel and Ethinyl Estradiol Tablets Sales and Marketing
7.4.1 Desogestrel and Ethinyl Estradiol Tablets Sales Channels
7.4.2 Desogestrel and Ethinyl Estradiol Tablets Distributors
7.5 Desogestrel and Ethinyl Estradiol Tablets Customers
8 Desogestrel and Ethinyl Estradiol Tablets Market Dynamics
8.1 Desogestrel and Ethinyl Estradiol Tablets Industry Trends
8.2 Desogestrel and Ethinyl Estradiol Tablets Market Drivers
8.3 Desogestrel and Ethinyl Estradiol Tablets Market Challenges
8.4 Desogestrel and Ethinyl Estradiol Tablets Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables
Table 1. Global Desogestrel and Ethinyl Estradiol Tablets Market Value Comparison by Type (2025-2031) & (US$ Million)
Table 2. Global Desogestrel and Ethinyl Estradiol Tablets Market Value Comparison by Application (2025-2031) & (US$ Million)
Table 3. Global Desogestrel and Ethinyl Estradiol Tablets Market Competitive Situation by Manufacturers in 2024
Table 4. Global Desogestrel and Ethinyl Estradiol Tablets Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Desogestrel and Ethinyl Estradiol Tablets Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Desogestrel and Ethinyl Estradiol Tablets Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Desogestrel and Ethinyl Estradiol Tablets Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Desogestrel and Ethinyl Estradiol Tablets Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Desogestrel and Ethinyl Estradiol Tablets, Industry Ranking, 2023 VS 2024 VS 2025
Table 10. Global Key Manufacturers of Desogestrel and Ethinyl Estradiol Tablets, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Desogestrel and Ethinyl Estradiol Tablets, Product Type & Application
Table 12. Global Key Manufacturers of Desogestrel and Ethinyl Estradiol Tablets, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Desogestrel and Ethinyl Estradiol Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Desogestrel and Ethinyl Estradiol Tablets as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Desogestrel and Ethinyl Estradiol Tablets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Desogestrel and Ethinyl Estradiol Tablets Sales by Region (2020-2025) & (K Units)
Table 18. Global Desogestrel and Ethinyl Estradiol Tablets Sales Market Share by Region (2020-2025)
Table 19. Global Desogestrel and Ethinyl Estradiol Tablets Sales by Region (2026-2031) & (K Units)
Table 20. Global Desogestrel and Ethinyl Estradiol Tablets Sales Market Share by Region (2026-2031)
Table 21. Global Desogestrel and Ethinyl Estradiol Tablets Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Desogestrel and Ethinyl Estradiol Tablets Revenue Market Share by Region (2020-2025)
Table 23. Global Desogestrel and Ethinyl Estradiol Tablets Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Desogestrel and Ethinyl Estradiol Tablets Revenue Market Share by Region (2026-2031)
Table 25. North America Desogestrel and Ethinyl Estradiol Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Desogestrel and Ethinyl Estradiol Tablets Sales by Country (2020-2025) & (K Units)
Table 27. North America Desogestrel and Ethinyl Estradiol Tablets Sales by Country (2026-2031) & (K Units)
Table 28. North America Desogestrel and Ethinyl Estradiol Tablets Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Desogestrel and Ethinyl Estradiol Tablets Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Desogestrel and Ethinyl Estradiol Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Desogestrel and Ethinyl Estradiol Tablets Sales by Country (2020-2025) & (K Units)
Table 32. Europe Desogestrel and Ethinyl Estradiol Tablets Sales by Country (2026-2031) & (K Units)
Table 33. Europe Desogestrel and Ethinyl Estradiol Tablets Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Desogestrel and Ethinyl Estradiol Tablets Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Desogestrel and Ethinyl Estradiol Tablets Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Desogestrel and Ethinyl Estradiol Tablets Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Desogestrel and Ethinyl Estradiol Tablets Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Desogestrel and Ethinyl Estradiol Tablets Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Desogestrel and Ethinyl Estradiol Tablets Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Desogestrel and Ethinyl Estradiol Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Desogestrel and Ethinyl Estradiol Tablets Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Desogestrel and Ethinyl Estradiol Tablets Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Desogestrel and Ethinyl Estradiol Tablets Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Desogestrel and Ethinyl Estradiol Tablets Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Desogestrel and Ethinyl Estradiol Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East & Africa Desogestrel and Ethinyl Estradiol Tablets Sales by Country (2020-2025) & (K Units)
Table 47. Middle East & Africa Desogestrel and Ethinyl Estradiol Tablets Sales by Country (2026-2031) & (K Units)
Table 48. Middle East & Africa Desogestrel and Ethinyl Estradiol Tablets Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East & Africa Desogestrel and Ethinyl Estradiol Tablets Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Desogestrel and Ethinyl Estradiol Tablets Sales (K Units) by Type (2020-2025)
Table 51. Global Desogestrel and Ethinyl Estradiol Tablets Sales (K Units) by Type (2026-2031)
Table 52. Global Desogestrel and Ethinyl Estradiol Tablets Sales Market Share by Type (2020-2025)
Table 53. Global Desogestrel and Ethinyl Estradiol Tablets Sales Market Share by Type (2026-2031)
Table 54. Global Desogestrel and Ethinyl Estradiol Tablets Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Desogestrel and Ethinyl Estradiol Tablets Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Desogestrel and Ethinyl Estradiol Tablets Revenue Market Share by Type (2020-2025)
Table 57. Global Desogestrel and Ethinyl Estradiol Tablets Revenue Market Share by Type (2026-2031)
Table 58. Global Desogestrel and Ethinyl Estradiol Tablets Price (US$/Unit) by Type (2020-2025)
Table 59. Global Desogestrel and Ethinyl Estradiol Tablets Price (US$/Unit) by Type (2026-2031)
Table 60. Global Desogestrel and Ethinyl Estradiol Tablets Sales (K Units) by Application (2020-2025)
Table 61. Global Desogestrel and Ethinyl Estradiol Tablets Sales (K Units) by Application (2026-2031)
Table 62. Global Desogestrel and Ethinyl Estradiol Tablets Sales Market Share by Application (2020-2025)
Table 63. Global Desogestrel and Ethinyl Estradiol Tablets Sales Market Share by Application (2026-2031)
Table 64. Global Desogestrel and Ethinyl Estradiol Tablets Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Desogestrel and Ethinyl Estradiol Tablets Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Desogestrel and Ethinyl Estradiol Tablets Revenue Market Share by Application (2020-2025)
Table 67. Global Desogestrel and Ethinyl Estradiol Tablets Revenue Market Share by Application (2026-2031)
Table 68. Global Desogestrel and Ethinyl Estradiol Tablets Price (US$/Unit) by Application (2020-2025)
Table 69. Global Desogestrel and Ethinyl Estradiol Tablets Price (US$/Unit) by Application (2026-2031)
Table 70. Cipla Corporation Information
Table 71. Cipla Description and Business Overview
Table 72. Cipla Desogestrel and Ethinyl Estradiol Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Cipla Desogestrel and Ethinyl Estradiol Tablets Product
Table 74. Cipla Recent Developments/Updates
Table 75. Bayer Corporation Information
Table 76. Bayer Description and Business Overview
Table 77. Bayer Desogestrel and Ethinyl Estradiol Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Bayer Desogestrel and Ethinyl Estradiol Tablets Product
Table 79. Bayer Recent Developments/Updates
Table 80. Merck Corporation Information
Table 81. Merck Description and Business Overview
Table 82. Merck Desogestrel and Ethinyl Estradiol Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Merck Desogestrel and Ethinyl Estradiol Tablets Product
Table 84. Merck Recent Developments/Updates
Table 85. Teva Pharmaceutical Corporation Information
Table 86. Teva Pharmaceutical Description and Business Overview
Table 87. Teva Pharmaceutical Desogestrel and Ethinyl Estradiol Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Teva Pharmaceutical Desogestrel and Ethinyl Estradiol Tablets Product
Table 89. Teva Pharmaceutical Recent Developments/Updates
Table 90. Allergan Corporation Information
Table 91. Allergan Description and Business Overview
Table 92. Allergan Desogestrel and Ethinyl Estradiol Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Allergan Desogestrel and Ethinyl Estradiol Tablets Product
Table 94. Allergan Recent Developments/Updates
Table 95. Pfizer Corporation Information
Table 96. Pfizer Description and Business Overview
Table 97. Pfizer Desogestrel and Ethinyl Estradiol Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Pfizer Desogestrel and Ethinyl Estradiol Tablets Product
Table 99. Pfizer Recent Developments/Updates
Table 100. Reckitt Benckiser Corporation Information
Table 101. Reckitt Benckiser Description and Business Overview
Table 102. Reckitt Benckiser Desogestrel and Ethinyl Estradiol Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Reckitt Benckiser Desogestrel and Ethinyl Estradiol Tablets Product
Table 104. Reckitt Benckiser Recent Developments/Updates
Table 105. Mankind Pharma Corporation Information
Table 106. Mankind Pharma Description and Business Overview
Table 107. Mankind Pharma Desogestrel and Ethinyl Estradiol Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Mankind Pharma Desogestrel and Ethinyl Estradiol Tablets Product
Table 109. Mankind Pharma Recent Developments/Updates
Table 110. Janssen Pharmaceutical Corporation Information
Table 111. Janssen Pharmaceutical Description and Business Overview
Table 112. Janssen Pharmaceutical Desogestrel and Ethinyl Estradiol Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Janssen Pharmaceutical Desogestrel and Ethinyl Estradiol Tablets Product
Table 114. Janssen Pharmaceutical Recent Developments/Updates
Table 115. HLL Lifecare Corporation Information
Table 116. HLL Lifecare Description and Business Overview
Table 117. HLL Lifecare Desogestrel and Ethinyl Estradiol Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. HLL Lifecare Desogestrel and Ethinyl Estradiol Tablets Product
Table 119. HLL Lifecare Recent Developments/Updates
Table 120. Mithra Pharmaceuticals Corporation Information
Table 121. Mithra Pharmaceuticals Description and Business Overview
Table 122. Mithra Pharmaceuticals Desogestrel and Ethinyl Estradiol Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Mithra Pharmaceuticals Desogestrel and Ethinyl Estradiol Tablets Product
Table 124. Mithra Pharmaceuticals Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Desogestrel and Ethinyl Estradiol Tablets Distributors List
Table 128. Desogestrel and Ethinyl Estradiol Tablets Customers List
Table 129. Desogestrel and Ethinyl Estradiol Tablets Market Trends
Table 130. Desogestrel and Ethinyl Estradiol Tablets Market Drivers
Table 131. Desogestrel and Ethinyl Estradiol Tablets Market Challenges
Table 132. Desogestrel and Ethinyl Estradiol Tablets Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Desogestrel and Ethinyl Estradiol Tablets
Figure 2. Global Desogestrel and Ethinyl Estradiol Tablets Market Value Comparison by Type (2025-2031) & (US$ Million)
Figure 3. Global Desogestrel and Ethinyl Estradiol Tablets Market Share by Type in 2024 & 2031
Figure 4. Short-acting Contraceptives Product Picture
Figure 5. Long-acting Contraceptives Product Picture
Figure 6. Global Desogestrel and Ethinyl Estradiol Tablets Market Value Comparison by Application (2025-2031) & (US$ Million)
Figure 7. Global Desogestrel and Ethinyl Estradiol Tablets Market Share by Application in 2024 & 2031
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Global Desogestrel and Ethinyl Estradiol Tablets Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Desogestrel and Ethinyl Estradiol Tablets Market Size (2020-2031) & (US$ Million)
Figure 12. Global Desogestrel and Ethinyl Estradiol Tablets Sales (2020-2031) & (K Units)
Figure 13. Global Desogestrel and Ethinyl Estradiol Tablets Average Price (US$/Unit) & (2020-2031)
Figure 14. Desogestrel and Ethinyl Estradiol Tablets Report Years Considered
Figure 15. Desogestrel and Ethinyl Estradiol Tablets Sales Share by Manufacturers in 2024
Figure 16. Global Desogestrel and Ethinyl Estradiol Tablets Revenue Share by Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Desogestrel and Ethinyl Estradiol Tablets Players: Market Share by Revenue in 2024
Figure 18. Desogestrel and Ethinyl Estradiol Tablets Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2020 VS 2024
Figure 19. Global Desogestrel and Ethinyl Estradiol Tablets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 20. North America Desogestrel and Ethinyl Estradiol Tablets Sales Market Share by Country (2020-2031)
Figure 21. North America Desogestrel and Ethinyl Estradiol Tablets Revenue Market Share by Country (2020-2031)
Figure 22. United States Desogestrel and Ethinyl Estradiol Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 23. Canada Desogestrel and Ethinyl Estradiol Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Europe Desogestrel and Ethinyl Estradiol Tablets Sales Market Share by Country (2020-2031)
Figure 25. Europe Desogestrel and Ethinyl Estradiol Tablets Revenue Market Share by Country (2020-2031)
Figure 26. Germany Desogestrel and Ethinyl Estradiol Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. France Desogestrel and Ethinyl Estradiol Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. U.K. Desogestrel and Ethinyl Estradiol Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Italy Desogestrel and Ethinyl Estradiol Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Russia Desogestrel and Ethinyl Estradiol Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Asia Pacific Desogestrel and Ethinyl Estradiol Tablets Sales Market Share by Region (2020-2031)
Figure 32. Asia Pacific Desogestrel and Ethinyl Estradiol Tablets Revenue Market Share by Region (2020-2031)
Figure 33. China Desogestrel and Ethinyl Estradiol Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Japan Desogestrel and Ethinyl Estradiol Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. South Korea Desogestrel and Ethinyl Estradiol Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. India Desogestrel and Ethinyl Estradiol Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Australia Desogestrel and Ethinyl Estradiol Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. China Taiwan Desogestrel and Ethinyl Estradiol Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Indonesia Desogestrel and Ethinyl Estradiol Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Thailand Desogestrel and Ethinyl Estradiol Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Malaysia Desogestrel and Ethinyl Estradiol Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Latin America Desogestrel and Ethinyl Estradiol Tablets Sales Market Share by Country (2020-2031)
Figure 43. Latin America Desogestrel and Ethinyl Estradiol Tablets Revenue Market Share by Country (2020-2031)
Figure 44. Mexico Desogestrel and Ethinyl Estradiol Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Brazil Desogestrel and Ethinyl Estradiol Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Argentina Desogestrel and Ethinyl Estradiol Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Desogestrel and Ethinyl Estradiol Tablets Sales Market Share by Country (2020-2031)
Figure 48. Middle East & Africa Desogestrel and Ethinyl Estradiol Tablets Revenue Market Share by Country (2020-2031)
Figure 49. Turkey Desogestrel and Ethinyl Estradiol Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Desogestrel and Ethinyl Estradiol Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. UAE Desogestrel and Ethinyl Estradiol Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Global Sales Market Share of Desogestrel and Ethinyl Estradiol Tablets by Type (2020-2031)
Figure 53. Global Revenue Market Share of Desogestrel and Ethinyl Estradiol Tablets by Type (2020-2031)
Figure 54. Global Desogestrel and Ethinyl Estradiol Tablets Price (US$/Unit) by Type (2020-2031)
Figure 55. Global Sales Market Share of Desogestrel and Ethinyl Estradiol Tablets by Application (2020-2031)
Figure 56. Global Revenue Market Share of Desogestrel and Ethinyl Estradiol Tablets by Application (2020-2031)
Figure 57. Global Desogestrel and Ethinyl Estradiol Tablets Price (US$/Unit) by Application (2020-2031)
Figure 58. Desogestrel and Ethinyl Estradiol Tablets Value Chain
Figure 59. Desogestrel and Ethinyl Estradiol Tablets Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed

※参考情報

デソゲストレル錠とエチニルエストラジオール錠は、ホルモン剤を含む経口避妊薬の一種で、女性の生理機能にさまざまな影響を与えます。これらの薬剤は、女性の体内におけるホルモンバランスを調整し、思春期から更年期にかけての様々な生理的変化に対応するために設計されています。以下にその定義、特徴、種類、用途、関連技術について詳しく解説します。

まず、デソゲストレルとは、合成のプロゲスチン（黄体ホルモン類似物質）で、エチニルエストラジオールは、合成のエストロゲン（女性ホルモンの一種）です。これらは、避妊効果を高めるために組み合わされ、多くの経口避妊薬に含まれています。デソゲストレルは、排卵を抑制し、子宮内膜を薄くして妊娠を防ぎ、さらに精子が子宮に到達するのを妨げる作用を持っています。一方、エチニルエストラジオールは、周期的なホルモンの変動を調整することで、ホルモンバランスを安定させる効果があります。

特徴としては、デソゲストレルとエチニルエストラジオールの組み合わせは、特に他のホルモン避妊薬に比べて副作用が少なく、使用者からの評価が高い点が挙げられます。また、1日1回の服用が基本で、コンスタントに服用することで高い避妊効果を得られることも魅力の一つです。経口避妊薬は、月経周期を整える効果もあるため、月経痛や過多月経の軽減にも寄与します。

これらの薬剤にはいくつかの種類が存在します。一般的には、デソゲストレルとエチニルエストラジオールを含むさまざまなブランド名の商品が市販されており、含有量や配合成分が異なるものがあります。これにより、使用者の体質やライフスタイルに合わせた選択が可能となります。

用途としては、主に避妊目的で使用されますが、それだけでなく治療的な側面も持っています。例えば、月経不順や重度の生理痛、またはニキビ治療などにも効果があるとされ、婦人科での処方が行われることも珍しくありません。また、妊娠のリスクを軽減することで、思春期における若年者の教育やライフプランにも寄与するため、社会的な意義も大きいと言えます。

関連技術としては、服用方法や製剤技術の進化が挙げられます。以前は、ホルモン量が多く副作用があった経口避妊薬が多かったですが、最近では低用量のものが増えており、ホルモンのバランスを崩さずに避妊効果を得ることができるようになっています。また、医療機関での指導やサポートが充実してきており、安全に使用するための情報提供がなされています。

副作用については、どのような薬剤にもリスクが伴います。デソゲストレルとエチニルエストラジオールを含む経口避妊薬も例外ではなく、例えば頭痛、吐き気、体重増加、気分の変動などが報告されています。重篤な副作用としては、血栓症のリスクがあるため、特に喫煙者や心血管疾患のリスクが高い方は使用に際し注意が必要です。このため、服用前に医師との十分なカウンセリングが重要です。

また、最近では自宅での健康管理が進み、スマートフォンアプリやウェアラブルデバイスを利用した健康管理方法も登場しています。これにより、ホルモンバランスや月経周期をデジタルで管理しやすくなっています。これらの技術は、避妊薬の厳守や副作用のモニタリングに役立ち、有用な情報を提供する役割を果たします。

デソゲストレル錠とエチニルエストラジオール錠は、近代的な女性医療において非常に重要な役割を果たしています。その便利さや効果性は、多くの女性にとって生活の質を向上させるものであり、今後もさらなる研究や技術革新が期待されます。避妊や生理に関する悩みを持つ女性にとって、これらの薬剤は、選択肢の一つとして有意義な存在であると言えるでしょう。医療現場では、適切な知識を持った医師との対話を通じて、自分に最適な方法を見つけることが重要です。既存の情報を基に、自分自身の健康を守るための選択を行っていく姿勢が求められます。


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • エストラジオール検査キットの世界市場2025-2031：時間分解免疫蛍光法、化学発光免疫測定法
  • ボルチオキセチン臭化水素酸塩錠の世界市場2025年：5mg、10mg、20mg
  • 炭酸リチウム錠剤＆カプセルの世界市場2025年：炭酸リチウム錠、炭酸リチウムカプセル
  • トラゾドン塩酸塩錠の世界市場2025年：50mg、100mg、150mg、300mg
  • セフィキシム分散錠の世界市場2025年：50mg、100mg、200mg
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA8735 )"デソゲストレル錠＆エチニルエストラジオール錠の世界市場2025年：短時間作用型避妊薬、長時間作用型避妊薬" (英文：Global Desogestrel and Ethinyl Estradiol Tablets Market Research Report 2025)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。